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Endogenous antioxidant enzymes and glutathione
S.transferase in protection of mesothelioma cells
against hydrogen peroxide and epirubicin toxicity
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Summary We have previously shown that cultured malignant mesothelioma cells contain elevated manganese superoxide dismutase
(MnSOD) mRNA levels and activities compared with non-malignant mesothelial cells. As many cytotoxic drugs generate both superoxide and
hydrogen peroxide, we assessed the relative significance of catalase and the glutathione redox cycle, as well as glutathione S-transferase
(GST), in protecting these cells against hydrogen peroxide and epirubicin toxicity. Mesothelioma cell lines containing high (M38K cells) and
low (M14K cells) MnSOD, and non-malignant MeT-5A mesothelial cells were selected for the study. M38K cells were the most resistant of
these three cell types to hydrogen peroxide (0.1-0.5 mm, 4 h) and epirubicin (0.1-0.5,g ml-', 48 h) as judged by lactate dehydrogenase
(LDH) release and by high-energy nucleotide (ATP, ADP, AMP) depletion. Total glutathione was higher in M38K cells (63.8 ± 20.3 nnmol mg-1
protein) than in M14K (25.2 ± 8.2 nmol mg-') or MeT-5A cells (23.5 ± 4.5 nmol mg-'). Furthermore, GST specific activity was higher in M38K
cells (111.3 ± 15.8 U mg-') than in M14K cells (77.4 ± 6.6 U mg-') or in MeT-5A cells (68.8 ± 7.6 U mg-'). Western blotting indicated the
presence of GST-i in all these cells, the reactivity again being highest in M38K cells. Depletion of glutathione by buthionine sulphoximine and
inhibition of catalase by aminotriazole enhanced hydrogen peroxide toxicity in all cell types, while only the depletion of glutathione increased
epirubicin toxicity. We conclude that simultaneous induction of multiple antioxidant enzymes can occur in human mesothelioma cells. In
addition to the high MnSOD activity, hydrogen peroxide scavenging antioxidant enzymes, glutathione and GST can partly explain the high
hydrogen peroxide and epirubicin resistance of these cells in vitro.
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Many chemotherapeutic agents generate reactive oxygen species
(ROS), such as superoxide and hydrogen peroxide. However, the
role of superoxide dismutases and hydrogen peroxide scavenging
antioxidant enzymes (AOEs) in tumour resistance is still unclear.
Most previous studies have suggested that levels of the super-
oxide radical-scavenging superoxide dismutases CuZnSOD and
manganese superoxide dismutase (MnSOD) are low in tumours
(reviewed by Sun, 1990), and ithas been suggested that MnSOD is
an anti-cancer gene (Church et al, 1993). Antioxidant and detoxifi-
cation mechanisms that can be involved in the drug resistance of
various tumours include glutathione (Russo and Mitchell 1985;
Meijer et al, 1987; Al-Kabban et al, 1990; Sun, 1990; Godwin et
al, 1992; Meijer et al, 1993), glutathione S-transferase (GST)
(Batist et al, 1986; Green et al, 1993; Hao et al, 1994; Tew, 1994;
Ban et al, 1996; Segers et al, 1996), y-glutamylcysteine synthetase
(Dusre et al, 1989; Bailey et al, 1992; Mulcahy et al, 1995; Yao
et al, 1995; Kuo et al, 1996), y-glutamyl transpeptidase (Elakawi
et al, 1996) and glutathione peroxidase (Meier et al, 1987; Sinha
and Mimnaugh, 1990; Ogawa et al, 1993; Hao et al, 1994). Poly-
morphism of GSTM1 is associated with increased risk for the
development of bronchogenic carcinoma (Kihara et al, 1993;
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Anttila et al, 1994) and mesothelioma (Hirvonen et al, 1995). On
the other hand, many tumours and tumour cell lines exhibit high
levels of GST-it, which, at least in certain cases appears to corre-
late with survival and/or acquired resistance to cytotoxic drugs
(Batist et al, 1986; Sharma et al, 1993; Mulder et al, 1995; Cheng,
1997). Only a few studies are available on the significance ofcata-
lase in malignant tumours, and most but not all suggest that cata-
lase does not play an important role in tumour resistance (Akman
et al, 1989; Sinha and Mimnaugh, 1990).
Human pleural mesothelioma is a resistant and fatal tumour
associated with occupational exposure to asbestos fibres, and its
pathogenesis is possibly mediatedby free radicals (Mossman etal,
1990; Kamp et al, 1992). Asbestos fibres have been shown to
cause up-regulation of MnSOD, an important mitochondrial
superoxide radical-scavenging enzyme, in bronchial epithelial
cells and mesothelial cells (Mossman et al, 1986; Janssen et al,
1994). We have previously shown that human mesothelioma cells
contain high MnSOD levels and that these mesothelioma cells are
more resistant than non-malignant mesothelial cells against the
exogenous oxidant menadione (Kinnula et al, 1996). Because
cytotoxic drugs generate both superoxide and hydrogen peroxide,
it is likely that hydrogen peroxide-scavenging mechanisms are
also involved in the observed resistance of this tumour against
oxidant producing chemotherapeutic drugs.
Most previous studies conducted on tumour cells have over-
looked the possibility of simultaneous induction of many anti-
oxidant enzymes and have focused only on one, often transfected
enzyme. No studies are available on the relative significance of
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hydrogen peroxide-scavenging antioxidant enzymes in human
mesothelioma. We investigated the relative role ofthe most impor-
tant hydrogen peroxide-scavenging AOEs catalase and glutathione
peroxidase, glutathione and the detoxification enzyme GST on
oxidant and drug resistance in human mesothelioma cells that had
been established from the tumours of untreated mesothelioma
patients. Cells that had been pretreated with aminotriazole to in-
activate catalase or with buthionine sulphoximine to cause gluta-
thione depletion were exposed to either hydrogen peroxide or to
epirubicin and were assessed for the development of cell injury.
Epirubicin was chosen as it has been shown to generate free radi-
cals intracellularly (Sinha and Mimnaugh, 1990), and it has been
widely used in the treatment ofmesothelioma.
METHODS
Cell culture
Previously characterized (Pelin-Enlund et al, 1990) continuous
mesothelioma cell line cells (M38K, M14K) were cultured on
uncoated plastic plates in RPMI 1640 medium (Gibco Europe,
Paisley, UK) supplemented with heat-inactivated 10% fetal calf
serum and the antibiotics streptomycin and penicillin. M38K
mesothelioma cell lines contain the highest and M14K cells the
lowest MnSOD activities of five mesothelioma cell lines estab-
lished from the tumours of our untreated mesothelioma patients.
Transformed human pleural mesothelial cells (MeT-5A), which
are SV-40 virus immortalized, diploid and non-malignant human
pleural mesothelial cells (Ke et al, 1989) were a gift from the
National Cancer Institute, Bethesda, USA (Dr CC Harris). They
were cultured in conditions and medium similar to those for the
mesothelioma cell line cells.
Pretreatments and oxidant exposures
Cells were pretreated with 20 mm aminotriazole (ATZ) for 60 min
to inactivate catalase or with 0.2 mm or 1 mM buthionine sulphox-
imine (BSO) for 16-18 h to inhibit y-glutamylcysteine synthetase
and to cause glutathione depletion. Both these inhibitors are
widely used, specific and their effects have been confirmed in
earlier investigations (Margoliash et al, 1960; Buckley et al, 1991;
Kinnula et al, 1992ab). Based on preliminary experiments and
cytotoxicity measurements, 0.2 mm BSO concentration was
selected forthe pretreatment ofMeT-5A cells and M14K cells, and
1 mM BSO for the pretreatment of M38K cells. Untreated and
pretreated cells after one washing were exposed to 0.1-0.5 mM
hydrogen peroxide for 1-4 h or to 0.1-0.5 jg ml-1 epirubicin
(0.17-0.85 mM) for 48 h. In the epirubicin experiments, the ATZ
treatment was repeated after 24 h for 60 min, and the last 16-h
incubation with epirubicin was conducted in the presence ofBSO.
Adenine nucleotides
High energy nucleotide catabolism is an early and sensitive
marker ofcell injury. To measure the proportion ofthe high energy
nucleotides in the cells, they were preincubated for 16 h with
0.1 mM ['4C]adenine (specific activity 51-55 mCi mmol-1;
Amersham International, Amersham, UK). Prelabelled cells were
washed and exposed to hydrogen peroxide or epirubicin. After the
exposures, the medium was removed and the cells were extracted
with 0.4 M perchloric acid. The purine nucleotides (ATP, ADP,
AMP) in both the cell extract and the medium and the nucleotide
catabolic products (xanthine, hypoxanthine, uric acid) in the
medium were separated by thin-layer chromatography as de-
scribed (Aalto and Raivio, 1990). The results are expressed as per
cent distribution ofradioactivity (counts per min, c.p.m.) between
nucleotides in the cells, nucleotides leaked into the medium and
catabolic products in the medium. Normally, the cell membrane of
intact cells is not permeable to the cellular high-energy nucleo-
tides, whereas their catabolic products are freely diffusible. Thus,
the appearance of nucleotides in the extracellular medium is one
way to assess cell membrane injury.
Lactate dehydrogenase (LDH) release
LDH release into the medium was measured by spectrophotometry
using pyruvic acid as the substrate (Bergmeyer, 1974). Total
cellular LDH was measured in cell lysates obtained by 1% Triton
X-100 treatment.
Antioxidant enzyme activities and glutathione
Total superoxide dismutase (SOD) activity was measured spectro-
photometrically using the method ofMcCord and Fridovich (1969).
MnSOD activity was distinguished from CuZnSOD activity by its
resistance to 1 mm potassium cyanide. Glutathione peroxidase
activity was analysed by following NADPH oxidation in the pres-
ence oft-butylhydroperoxide (Beutler, 1975). Catalase activity was
determined using a Clark oxygen electrode as described (Kinnula et
al, 1992b). Glutathione S-transferase (GST) was measured spectro-
photometrically using 1 mm 1-chloro-2,4-dinitrobenzene and 1 mM
glutathione (Habig and Jakoby, 1981). Enzyme activities are
expressed as U mg-' protein. Total glutathione content was deter-
mined spectrophotometrically following the reduction of 5,5'-
dithiobis (2-nitrobenzoic) acid by NADPH in the presence of
glutathione reductase (Beutler, 1975). Glutathione content is
expressed as nmol mg-' protein. Proteins were analysed by the
micro method ofBioRad (Hercules, CA, USA).
Western blotting
The cells were detached with trypsin, centrifuged and washed with
phosphate-buffered saline (PBS). Suspended cells in the sample
buffer were boiled for 5 min at 95°C, and 30gg ofprotein per lane
was applied. The gel was electrophoresed for 1.5 h (90 V), and the
protein was transferred onto Hybond enhanced chemiluminescence
(ECL) nitrocellulose membrane (Amersham International, Buck-
inghamshire, UK). Blotted membrane was incubated with rabbit
antibody to GST-i (BioPrep, Dublin, Ireland; diluted 1:5000),
followed by treatment with donkey anti-rabbit antibody conjugated
to horseradish peroxidase (Amersham) (dilution 1:30 000). GST P
was detected using the ECL system (Amersham), and luminol exci-
tation was imaged on radiographic film. The amount ofthe loading
was assessed relative to beta actin. Anti-actin antibody (Sigma
Chemical, MO, USA) was used in a dilution of 1:20 000.
Statistical analysis
Data are expressed as mean ± s.d. The groups were compared by
analysis of variance and Scheffe's post hoc test; P < 0.05 was
considered to be significant.
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Figure 1 LDH release from MeT-5A cells, M14K cells and M38K cells after
a 4-h exposure to hydrogen peroxide. The cell injury is expressed as relative
LDH release compared with non-exposed cells. *P< 0.05 vs non-exposed
cells
RESULTS
M38K cells were most resistant to hydrogen peroxide when
assessed by LDH release (Figure 1) or depletion of high-energy
nucleotides (not shown). In order to investigate the relative impor-
tance of the hydrogen peroxide-scavenging mechanisms catalase
and glutathione redox cycle in cell protection, the cells were
pretreated with aminotriazole (ATZ) or with buthionine sulphox-
imide (BSO). After 20 mM ATZ, the activity ofcatalase decreased
by 85% in MeT-5A cells, 82% in M14K cells and 89% in M38K
cells (two duplicate experiments). Baseline total glutathione
content was 63.8 ± 20.3 nmol mg-1 protein (n=3) in M38K cells
25.2 ± 8.2 nmol mg-' protein (n = 3) in M14K cells and 23.5 +
4.5 nmol mg-' protein (n = 3) in MeT-5A cells. BSO at a concen-
tration of0.2 mm decreased the glutathione concentration in MeT-
5A and M14K cells to non-measurable levels. After 0.2 mM BSO
treatment, 9.3 ± 7.1 nmol mg-1 (n = 3) glutathione was measured
in M38K cells (15% of baseline), while the corresponding value
after 1 mm BSO treatment was 4.4 ± 0.1 nmol mg-' (n = 3) (7% of
baseline). Therefore, 0.2 mm BSO was used for pretreatment of
MeT-SA and M14K cells and 1.0 mm BSO for M38K cells. ATZ
and 0.2 mm BSO as such did not cause adenine nucleotide deple-
tion in any of these cells, whereas 1 mm BSO induced significant
nucleotide catabolism in M14K cells (not shown).
Preliminary experiments indicated that 0.1 mM hydrogen
peroxide caused significant nucleotide efflux and catabolism in
MeT-SA cells and M14K cells but not in M38K cells; however
neither BSO nor ATZ pretreatment could sensitize M38K cells to
the effects of 0.1 mm hydrogen peroxide (not shown). Therefore,
pretreated MeT-SA cells and M14K cells were exposed to 0.1 mM
hydrogen peroxide and pretreated M38K cells to 0.5 mM hydrogen
peroxide for 4 h. Hydrogen peroxide enhanced adenine nucleotide
catabolism in MeT-SA and M38K cells pretreated with ATZ or
BSO, whereas in M14K cells only BSO pretreatment potentiated
nucleotide depletion (Figure 2).
In preliminary experiments, epirubicin at a concentration of
0.1Igg ml-' caused significant nucleotide catabolism in MeT-SA
cells and M14K cells, but not in untreated or pretreated M38K
cells (data not shown). Therefore, pretreated MeT-SA and M14K
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Figure 2 Nucleotide depletion, catabolite accumulation and leakage of
intact nucleotides of ATZ- and BSO-pretreated and hydrogen peroxide-
exposed MeT-5A (A), M14K (B) and M38K cells (C). MeT-5A cells and M14K
cells were exposed to 100gM hydrogen peroxide and M38K cells to 500gM
hydrogen peroxide. Values are means ± s.d. from four to six separate
experiments. *P< 0.05 vs hydrogen peroxide-exposed non-treated cells
cells were exposed to 0.1Igg ml' epirubicin and M38K cells to
0.5 jg ml' epirubicin for 48 h. BSO potentiated epirubicin toxi-
city in all three cell types, when assessedby nucleotide catabolism,
whereas ATZ pretreatment had no effect on the cellular nucleotide
levels in any ofthese cells (Figure 3).
Intracellular CuZnSOD, MnSOD, glutathione peroxidase and
catalase activities in these cells have been (Kinnula et al, 1996) or
will be published as part of a study of their gene expression
(Kahlos et al, 1998). A summary of those results as well as total
glutathione content and total GST activity in the cell lines studied
are presented in Table 1. Given that total GST activity was highest
in M38K cells and that GST-i isoenzyme is highly involved in the
drug resistance of many tumours, GST-i was further assessed
by Western blotting. The results indicated that GST-t was most
prominently expressed in M38K cells (Figure 4), suggesting that
this isoenzyme may play a signficant role in the drug resistance of
these cells.
British Journal ofCancer(1998) 77(7), 1097-1102 0 CancerResearch Campaign 1998Table 1 CuZn superoxide dismutase (CuZnSOD), manganese superoxide
dismutase (MnSOD), glutathione peroxidase (Gpx), catalase (Cat) and total
glutathione S-transferase (GST) activities and intracellular total glutathione
content in MeT-5A, M14K and M38K cells
MeT-5A M14K M38K
CuZnSOD 11.6 ± 13.7 20.1 ± 5.8 31.7± 11.9
MnSOD 4.0 ± 3.4 10.0 ± 6.0* 41.0± 19.1*
Gpx 1.0 ± 0.4 1.9 ± 1.6 2.7± 2.1
Cat 13.7 ± 4.9 8.1 ± 3.3 24.5 ± 7.5**
GST 68.8± 7.6 77.4± 6.6 111.3± 15.8**
Glutathione 23.5 ± 4.5 25.2 ± 8.2 63.8 ± 20.3**
Activities are expressed as U mg-' protein or mU mg-' protein (Gpx).
Glutathione concentration is expressed as nmol mg-' protein. Values are
means ± s.d., n = 6-8, *P < 0.05 vs MeT-5A, **P< 0.05 vs MeT-5A and
M14K.
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Figure 3 Nucleotide depletion, catabolite accumulation and leakage of
intact nucleotides of ATZ- and BSO-pretreated and epirubicin-exposed (48 h)
MeT-5A (A), M14K (B) and M38K (C) cells. The epirubicin concentrations
were 0.1 ,ug ml- for MeT-5A cells and M14K cells,and 0.5 gg ml-' for M38K
cells. Values are means±s.d. from four to six separate experiments. *P <
0.05 vs epirubicin-exposed non-treated cells 0
Met-5A
DISCUSSION
Mesothelioma is highly resistant to all forms ofchemotherapy and
radiation. We have recently found that human mesothelioma cell
lines contain elevated MnSOD mRNA and activity compared with
non-malignant mesothelial cells (Kinnula et al, 1996) and that
MnSOD is heavily immunostained in human mesothelioma
compared with healthy human pleural mesothelium (Kahlos et al,
1998). Out of all mesothelioma cell lines established from the
tumours of our untreated patients, M14K cells, which were used
here, have the lowest MnSOD activity. Previously, MnSOD has
been reported to be low in most tumours and tumourcells (Sinha et
al, 1990; Wong, 1995; Guner et al, 1996; Stammler et al, 1996),
and it appears to have antiproliferative effects (Church et al, 1993;
Li et al, 1995). However, the role of MnSOD in tumours is more
complicated than originally assumed. Recent studies have detected
high MnSOD levels in colon cancer (Nakano et al, 1996), thyroid
cancer (Nishida et al, 1996) and tumours ofcentral nervous origin
(Cobbs et al, 1996; Landriscina et al, 1996), and our data on M38K
Figure 4 Western blotting of GST-t in MeT-5A mesothelial cells, M14K and
M38K mesothelioma cells. The size (kDa) of the molecular marker is
indicated on the left in the upper panel. The lower panel shows the densities
of GST-r relative to beta actin from two separate experiments conducted in
duplicate. The results indicate highest GST-ir immunoreactivity in M38K
mesothelioma cells
cells show the same result in human mesothelioma (Kinnula et al,
1996). Tumours may have high immunoreactive protein without
elevated enzyme activity, but our mesothelioma cells also demon-
strated elevated specific activity ofMnSOD (Kinnula et al, 1996).
As SOD scavenges superoxide radicals to hydrogen peroxide, it
may not be the only antioxidant enzyme explaining oxidant or
drug resistance ofthe cells.
One potential mechanism for the high oxidant resistance of
mesothelioma cells is simultaneous induction of MnSOD and
hydrogen peroxide-scavenging mechanisms, such as catalase and
glutathione peroxidase, as well as the availability of glutathione,
which is required for the optimal function ofthe glutathione redox
British Journal ofCancer (1998) 77(7), 1097-1102
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cycle. M38K cells contained not only the highest activity of
MnSOD but also the highest catalase and glutathione levels and
somewhat elevated glutathione peroxidase activity. They were also
most resistant to hydrogen peroxide and to epirubicin of the cell
lines studied. This result is consistent with previous studies, that
have shown that a combination of superoxide- and hydrogen
peroxide-scavenging AOEs offers better protection against exoge-
nous oxidants than SOD alone (Freeman et al, 1985; Buckley et al,
1987; McCord, 1993; Kinnula et al, 1995b). Furthermore, the
induction of MnSOD alone is not necessarily protective against
oxidant exposure in vitro (Kinnula et al, 1995a and b), and
increased SOD-glutathione peroxidase ratio can increase
hydrogen peroxide production and promote cell senescence (De
Haan et al, 1996). Therefore, simultaneous induction of SOD and
hydrogen peroxide-scavenging pathways may be critical for the
resistance of human mesothelioma cells against oxidants and
oxidant-producing agents.
Catalase has not usually been connected to drug resistance
(Sinha and Mimnaugh, 1990; Coursin et al, 1996). Catalase can be
inhibited with ATZ in the presence of hydrogen peroxide but,
because complete inhibition is impossible to achieve (Margoliash,
1960; Kinnula et al, 1992a), such inhibition studies underestimate
the role of catalase in oxidant-exposed cells. In the present study,
catalase inhibition potentiated hydrogen peroxide toxicity in the
most resistant cell type (M38K), suggesting a function of catalase
during heavy oxidant exposure. On the other hand, ATZ had no
effect on epirubicin toxicity in any ofthese cells. This finding does
not exclude the importance of catalase in mesothelioma, but it
suggests that catalase does not play a central role in the resistance
of mesothelioma cells against free radical-generating drugs. In
addition, it has to be emphasized that, although ATZ and BSO have
been widely used as specific inhibitors ofcatalase and y-glutamyl-
cysteine synthetase, the results obtained in the presence of these
inhibitors represent indirect data that can theoretically affect other
unknown parameters of the cells. Furthermore, the differences
between hydrogen peroxide and epirubicin in ATZ- and BSO-
treated cells may also be related to the glutathione related drug
efflux pump (Ishikawa, 1992; Muller et al, 1994) in these cells.
GST has been widely investigated previously, but its role in
various tumours is still incompletely defined. For instance, many
but not all studies have shown that tumour cell lines transfected
with GST cDNA are resistant to cytotoxic drugs (reviewed by
Tew, 1994). In agreement with our study, certain drug-resistant
tumour cell lines have been shown to contain elevated levels of
multiple antioxidative and detoxification mechanisms, such as
total glutathione, glutathione peroxidase and GST (Hao et al,
1994) or y-glutamylcysteine synthetase (Kuo et al, 1996). In addi-
tion, small-cell lung carcinoma cell lines established after
chemotherapy have been reported to develop resistance to doxoru-
bicin with a simultaneous increase of glutathione, GST and cata-
lase (De Vries et al, 1989). In our study, M38K cells contained the
highest glutathione, total GST activity and GST-i immuno-
reactivity, suggesting the importance of an ideal balance between
glutathione and glutathione-dependent detoxification enzymes in
the resistance of these cells to oxidants and at least to some
chemotherapeutic compounds. As multiple GST isoenzymes have
been characterized, GST-i is not necessarily the only GST type
that can be modulated in these cells.
We conclude that antioxidant enzyme levels in mesothelioma
cells can be variable. Elevated MnSOD, hydrogen peroxide-
scavenging AOEs in combination with glutathione and GST play a
more important role than any single antioxidant enzyme in the
oxidant and drug resistance ofthese cells in vitro.
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